LPL Financial
DNA icon

LPL Financial’s Ginkgo Bioworks DNA Stock Holding History

LPL Financial’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-55,000
Closed -$448K – 5325
2024
Q3 		$448K Buy
55,000
+53,625
+3,900% +$537K ﹤0.01% 4090
2024
Q2 		$18.4K Buy
+1,375
New +$41K ﹤0.01% 4939

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

LPL Financial's DNA Position: Q2 2026 in Review

LPL Financial reduced its Ginkgo Bioworks (DNA) stake by 0.92% in Q2 2026, selling an estimated $3.36K and leaving 43,114 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #5156.

LPL Financial first reported a position in DNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $806K in Q4 2023. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • LPL Financial held 43,114 shares of Ginkgo Bioworks worth $427K as of Q2 2026.
  • LPL Financial sold 402 Ginkgo Bioworks shares in Q2 2026, an estimated $3.36K.
  • Ginkgo Bioworks made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5156 holding.
  • LPL Financial first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 19 quarters since.
  • LPL Financial's Ginkgo Bioworks position peaked at $806K in Q4 2023.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.